
Last Updated : 2020-07-03
A. | ADDRESS | |||||||||||||||
Head Office | : | Jl. Indofarma No.1 Cibitung Cikarang Barat Bekasi 17530 Indonesia Phone : (021) 8832-3971/75 Fax : (021) 8832-3972/73 Email : HTTP : www.indofarma.co.id |
||||||||||||||
Factory 1 | : | Kawasan Industri Batik Village Blok.H No.25 Kawasan Lippo Cikarang Jawa Barat Indonesia Phone : (021) 897-4243 Fax : (021) 897-2041 Email : HTTP : |
||||||||||||||
Factory 2 | : | Jl. Indofarma No.1 Cibitung Jawa Barat 17530 Indonesia Phone : (021) 8832-3975 8832-3971 Fax : (021) 8832-3972/73 Email : HTTP : |
||||||||||||||
B. | BUSINESS | : | Consumer Good Industry-Pharmaceutical | |||||||||||||
Sector Code | : | 53 | ||||||||||||||
Sector Name | : | Pharmaceuticals | ||||||||||||||
C. | COMPANY STATUS | : | PMDN | |||||||||||||
D. | FOUNDATION DATE | : | 02-01-1996 | |||||||||||||
Brief of Company Background | ||||||||||||||||
Established on January 2 1996, the company dates back to 1918 when it was a
pharmaceuticals factory known as Pabrik Obat Manggarai. In 1942, ownership
of this pharmaceuticals factory changed hands from the Dutch to the
Japanese government. In 1950, Pabrik Obat Manggarai was taken over by
the Indonesian government via the Department of Health, and became the
pharmaceuticals production center for this government department. In 1979,
the name of the factory changed to the Department of Health Pharmaceuticals
Production Center, a non-profit organization, whose primary task was to
produce essential medicines for public health care services. In 1981, the
name this production center was changed to Indonesia Farma (State
Utility). In anticipation of future growth and increased competition,
in 1996, the status of this company was changed to a limited company,
PT Indonesia Farma, or PT Indofarma for short. That year the company
also began expanding its local distribution network. In 1996, the company
acquired a 43.5% shareholding in PT Riasima Abadi Farma, a producer of
raw materials used in the production of pharmaceuticals. In January 2000,
the company set up subsidiary PT Indofarma Global Medika, to deal with
the distribution side of the company’s business. In March 2000, the
company acquired a 20% stake in PT Asindo Husada Bhakti, which was
set up to distribute pharmaceutical products through retail outlets.
In March 2001, the company made a public offering of its shares. Of the
funds raised from this offering, 53% was used to develop production
capacity and facilities, and 43% to augment working capital. |
||||||||||||||||
E. | SHAREHOLDER LIST | |||||||||||||||
|
||||||||||||||||
F. | FINANCIAL STATEMENT | |||||||||||||||
Fiscal Year Ends | : | December | ||||||||||||||
(In Million Rupiah except Par Value, Per Share Data and Ratios) | ||||||||||||||||
Statement Date | : | 2020-09-30(IDR) | 2019-12-31(IDR) | 2018-12-31(IDR) | 2017-12-31(IDR) | |||||||||||
Balance Sheet | ||||||||||||||||
Cash & Cash Equivalents | : | 27,100 | 151,388 | 129,325 | 182,588 | |||||||||||
Curr. Assets | : | 942,533 | 829,104 | 867,493 | 930,982 | |||||||||||
Fixed Assets | : | 548,813 | 554,832 | 574,858 | 598,893 | |||||||||||
Total Assets | : | 1,491,346 | 1,383,935 | 1,442,351 | 1,529,875 | |||||||||||
Curr. Liabilities | : | 568,977 | 440,827 | 827,238 | 893,289 | |||||||||||
Long Term Debt | : | 436,317 | 438,173 | 118,466 | 110,176 | |||||||||||
Minority Interest | : | 0 | 0 | 0 | 0 | |||||||||||
Total Liabilities | : | 1,005,294 | 879,000 | 945,704 | 1,003,465 | |||||||||||
Paid-Up Capital | : | 3,099 | 3,099 | 3,099 | 3,099 | |||||||||||
Total Equity | : | 486,052 | 504,935 | 496,647 | 526,410 | |||||||||||
Income Statement | ||||||||||||||||
Total Sales | : | 749,255 | 1,359,175 | 1,592,980 | 1,631,317 | |||||||||||
Gross Profit | : | 183,508 | 250,360 | 284,220 | 282,813 | |||||||||||
Operating Profit | : | 6,933 | 9,746 | 25,910 | -4,283 | |||||||||||
Net Income | : | -18,883 | 7,962 | -32,736 | -46,285 | |||||||||||
Cash Flow Statement | ||||||||||||||||
Cash from Operating Act | : | -96,631 | 20,791 | -70,391 | 147,184 | |||||||||||
Cash from Investing Act | : | -2,721 | 76,484 | -46,400 | -93,449 | |||||||||||
Cash from Financing Act | : | -24,286 | -75,027 | 63,805 | 72,967 | |||||||||||
Per Share Data (in IDR) | ||||||||||||||||
EPS | : | -8.12 | 2.57 | -10.56 | -14.93 | |||||||||||
Book Value | : | 156.83 | 162.92 | 160.25 | 169.85 | |||||||||||
Financial Ratios | ||||||||||||||||
Der | : | 2.07 | 1.74 | 1.90 | 1.91 | |||||||||||
Roa | : | -0.02 | 0.01 | -0.02 | -0.03 | |||||||||||
Roe | : | -0.05 | 0.02 | -0.07 | -0.09 | |||||||||||
Npm | : | -0.03 | 0.01 | -0.02 | -0.03 | |||||||||||
Opm | : | 0.01 | 0.01 | 0.02 | -0.00 | |||||||||||
Growth Year to Year | ||||||||||||||||
Sales (%) | : | 22.12 | -17.20 | -2.41 | -2.66 | |||||||||||
NetIncome (%) | : | -84.51 | 511.16 | -41.39 | 62.48 | |||||||||||
Total Assets (%) | : | 11.10 | -4.22 | -6.07 | 9.69 | |||||||||||
Total Liabilities (%) | : | 14.05 | -7.59 | -6.11 | 19.69 |
G. | MANAGEMENT | |||||||||||||||||||||||||
Commissioners | ||||||||||||||||||||||||||
President | : | Siswanto | ||||||||||||||||||||||||
Vice President | : | |||||||||||||||||||||||||
Commissioners | : | Nizar Yamanie; Teddy Wibisana (Independent) | ||||||||||||||||||||||||
Directors | ||||||||||||||||||||||||||
President | : | Rusdi Rosman | ||||||||||||||||||||||||
Vice President | : | |||||||||||||||||||||||||
Directors | : | Herry Triyatno; Eko Dodi Santosa | ||||||||||||||||||||||||
Audit Committee | ||||||||||||||||||||||||||
President | : | Teddy Wibisana | ||||||||||||||||||||||||
Vice President | : | |||||||||||||||||||||||||
Audit Committee | : | Suryadi; Warga Murad | ||||||||||||||||||||||||
H. | LISTING HISTORY | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||
I. | UNDERWRITERS | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||
J. | SHARE REGISTER | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||
K. | CASH DIVIDEND HISTORY | |||||||||||||||||||||||||
|